Literature DB >> 2610692

Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions.

E Holmberg1, K Maruyama, D C Litzinger, S Wright, M Davis, G W Kabalka, S J Kennel, L Huang.   

Abstract

Monoclonal antibody was conjugated to N-glutaryl-phosphatidylethanolamine in the presence of octylglucoside by using N-hydroxysulfosuccinimide as a carboxyl-activation reagent. The conjugated antibody was then incorporated into liposomes by a simple dialysis method. The method is mild and is compatible with various lipid compositions of the liposomes. We have prepared immunoliposomes containing a lung endothelium-specific monoclonal antibody and showed excellent target binding (approximately 75% injected dose) of the immunoliposomes in mouse. Immunoliposomes can be prepared to contain other acidic lipids such as phosphatidylserine and various amounts of cholesterol. The presence of 20% or more cholesterol in liposomes resulted in high level of target binding. We have used in these experiments a new radioactive lipid-phase marker, 111In-DTPA-SA, which was very stable in vivo. The halflife of clearance in mouse exceeded 3 weeks.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2610692     DOI: 10.1016/0006-291x(89)92740-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Immunotargeting of liposomes containing lipophilic antitumor prodrugs.

Authors:  A Mori; S J Kennel; L Huang
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

2.  Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice.

Authors:  V Weissig; K R Whiteman; V P Torchilin
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

3.  Lipid composition is important for highly efficient target binding and retention of immunoliposomes.

Authors:  K Maruyama; S J Kennel; L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.

Authors:  A Mori; S J Kennel; M van Borssum Waalkes; G L Scherphof; L Huang
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.

Authors:  Yin Duan; Lihui Wei; Julia Petryk; Terrence D Ruddy
Journal:  Int J Nanomedicine       Date:  2016-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.